BIOA insider transaction filings
BioAge Labs, Inc. — 49 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-01. Screen BIOA transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 1 Form 4 filing. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing by 1 insider — 62,566 shares, $1,576,752 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 42,350 shares @ $25.21 ($1,067,576) by Barton Shane, filed 2026-07-01.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Barton Shane — Principal Accounting Officer | 1 | — | 2 legs · 62,566 sh · $1,576,752 | 16 |
Recent Form 4 filings — BioAge Labs, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | Barton Shane — Principal Accounting Officer | Option exercise (M): 9,301 @ $10.85 · Option exercise (M): 7,261 @ $8.39 · Option exercise (M): 8,958 @ $4.30 · Option exercise (M): 14,198 @ $4.38 · Sale (S): 42,350 @ $25.21 · Option exercise (M): 4,290 @ $10.85 · +12 more | EDGAR |
| 2026-06-12 | 4 | Pande Vijay Satyanand — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Hemrajani Rekha — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Davidson Michael H. — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | ENRIGHT PATRICK G — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | HEALY JAMES — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | GARNIER JEAN PIERRE — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | GOLDSTEIN DOV A MD — Chief Financial Officer | Option exercise (M): 3,542 @ $4.38 · Option exercise (M): 3,542 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | RUBIN PAUL D — Chief Medical Officer | Option exercise (M): 5,437 @ $4.11 · Option exercise (M): 3,383 @ $6.57 · Sale (S): 8,820 @ $17.81 · Option exercise (M): 5,437 (derivative) @ $0 · Option exercise (M): 3,383 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | RUBIN PAUL D — Chief Medical Officer | Option exercise (M): 5,433 @ $4.11 · Option exercise (M): 2,000 @ $6.57 · Sale (S): 7,433 @ $20.30 · Option exercise (M): 5,433 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | GOLDSTEIN DOV A MD — Chief Financial Officer | Option exercise (M): 3,542 @ $4.38 · Option exercise (M): 3,542 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Morgen Eric — Chief Operating Officer, Director | Grant/award (A): 110,000 (derivative) @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Fortney Kristen — Chief Executive Officer, Director | Grant/award (A): 330,000 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Barton Shane — Principal Accounting Officer | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | RUBIN PAUL D — Chief Medical Officer | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | GOLDSTEIN DOV A MD — Chief Financial Officer | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | RUBIN PAUL D — Chief Medical Officer | Option exercise (M): 5,433 @ $4.11 · Option exercise (M): 2,000 @ $6.57 · Sale (S): 7,433 @ $18.75 · Option exercise (M): 5,433 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | GOLDSTEIN DOV A MD — Chief Financial Officer | Option exercise (M): 3,541 @ $4.38 · Option exercise (M): 3,541 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | GOLDSTEIN DOV A MD — Chief Financial Officer | Option exercise (M): 3,542 @ $4.38 · Option exercise (M): 3,542 (derivative) @ $0 | EDGAR |
| 2026-01-15 | 4 | Fortney Kristen — Chief Executive Officer, Director | Sale (S): 233,107 @ $18.12 | EDGAR |
| 2026-01-15 | 4 | GOLDSTEIN DOV A MD — Chief Financial Officer | Option exercise (M): 27,000 @ $8.39 · Sale (S): 8,974 @ $18.43 · Sale (S): 4,440 @ $19.45 · Sale (S): 11,663 @ $20.54 · Sale (S): 1,923 @ $21.08 · Option exercise (M): 27,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | RUBIN PAUL D — Chief Medical Officer | Option exercise (M): 5,433 @ $4.11 · Option exercise (M): 2,000 @ $6.57 · Sale (S): 7,433 @ $12.85 · Option exercise (M): 5,433 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | RUBIN PAUL D — Chief Medical Officer | Option exercise (M): 18,000 @ $6.57 · Sale (S): 18,000 @ $12 · Option exercise (M): 18,000 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | RUBIN PAUL D — Chief Medical Officer | Option exercise (M): 68,897 @ $4.11 · Sale (S): 68,897 @ $10.19 · Option exercise (M): 68,897 (derivative) @ $0 | EDGAR |
| 2025-08-11 | 4 | Pande Vijay Satyanand — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Hemrajani Rekha — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Davidson Michael H. — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | ENRIGHT PATRICK G — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | HEALY JAMES — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | GARNIER JEAN PIERRE — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Barton Shane — Principal Accounting Officer | Purchase (P): 2,632 @ $18 | EDGAR |
| 2025-03-10 | 4/A | Hemrajani Rekha — Director | Purchase (P): 3,000 @ $18 | EDGAR |
| 2025-02-25 | 4/A | Morgen Eric — Chief Operating Officer, Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | Morgen Eric — Chief Operating Officer, Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | Fortney Kristen — Chief Executive Officer, Director | Grant/award (A): 530,000 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | Barton Shane — Principal Accounting Officer | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | RUBIN PAUL D — Chief Medical Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | GOLDSTEIN DOV A MD — Chief Financial Officer | Grant/award (A): 170,000 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | Barton Shane — Principal Accounting Officer | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | Pande Vijay Satyanand — Director | Purchase (P): 126,793 @ $19.73 · Purchase (P): 67,096 @ $19.73 · Purchase (P): 25,306 @ $19.90 | EDGAR |
| 2024-10-01 | 4 | Cormorant Asset Management, LP Cormorant Private Healthcare Fund V LP Chen Bihua Cormorant Private Healthcare Fund IV LP | Conversion (C): 1,179,529 · Purchase (P): 450,000 @ $18 · Conversion (C): 5,263,772 (derivative) | EDGAR |
| 2024-09-27 | 4 | Pande Vijay Satyanand — Director | Conversion (C): 855,972 · Conversion (C): 413,100 · Conversion (C): 189,609 · Conversion (C): 655,294 · Purchase (P): 900,000 @ $18 · Conversion (C): 3,819,863 (derivative) · +3 more | EDGAR |
| 2024-09-27 | 4 | Fortney Kristen — Chief Executive Officer, Director | Grant/award (A): 424,827 (derivative) @ $0 · Grant/award (A): 708,044 (derivative) @ $0 | EDGAR |
| 2024-09-27 | 4 | Hemrajani Rekha — Director | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 28,497 (derivative) @ $0 | EDGAR |
| 2024-09-27 | 4 | Morgen Eric — Chief Operating Officer, Director | Grant/award (A): 4,952 (derivative) @ $0 · Grant/award (A): 257,973 (derivative) @ $0 · Grant/award (A): 13,598 (derivative) @ $0 | EDGAR |
| 2024-09-27 | 4 | Davidson Michael H. — Director | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 33,986 (derivative) @ $0 | EDGAR |
| 2024-09-27 | 4 | ENRIGHT PATRICK G — Director | Conversion (C): 1,310,589 · Purchase (P): 400,000 @ $18 · Grant/award (A): 15,000 (derivative) @ $0 · Conversion (C): 5,848,637 (derivative) | EDGAR |
| 2024-09-27 | 4 | HEALY JAMES — Director | Conversion (C): 1,638,236 · Purchase (P): 588,888 @ $18 · Purchase (P): 11,113 @ $18 · Purchase (P): 18,353 @ $18 · Purchase (P): 21,814 @ $18 · Purchase (P): 26,497 @ $18 · +2 more | EDGAR |
| 2024-09-27 | 4 | GARNIER JEAN PIERRE — Director | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 141,609 (derivative) @ $0 | EDGAR |
Recent 8-K events — BioAge Labs, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-24 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-20 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-04 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BIOA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →